… antioxidant capacity in the plasma of COVID-19 patients found in this study, particularly with
regard to GSH and related low-molecular-weight antioxidants… form of COVID-19 were not …

… of antioxidant systems play a major role in COVID-19 … by inhibiting endogenous antioxidant
enzymes such as NQO-1 … , is of particular interest as an anti-COVID-19 agent. GSH and NAC …

… , COVID-19 inclusive. This study aimed to examine the levels of some antioxidants and oxidative
stress markers in COVID-19 … plasma level of Os markers, PGF2α and MDA, in COVID-19 …

… Our results show that the OS markers in plasma such as LPO and TAC were increase
and decrease respectively, and inflammation markers such as the IL-6, CRP and PCT were …

… of antioxidant therapy as a complementary measure to the pharmacological treatment of
COVID-19 … of one or more of the following antioxidant compounds for the treatment of COVID-19. …

… COVID-19 and for the development of reasonable COVID-19 management strategies. …
abundant and important antioxidant molecules found in both cells and plasma and appear …

… The total antioxidant capacity (TAC) of plasma was evaluated by using the PAOT ® (Pouvoir
AntiOxydant Total, Institut Européen des Antioxydants, Nancy, France) score as previously …

… Patients with liver steatosis have increased LPO markers and proinflammatory cytokines
as well as reduced total plasma antioxidant capacity (TAC)[29]. Literature data presented that …

… between severe COVID-19 and oxidative stress markers, the clinical implication of this work
lies in the possible relationship between both and the development of antioxidant therapy, if …

… Here, we correlated the plasma oxidants/antioxidants levels of the elderly admitted to a long-…
like disease/COVID-19. Moreover, in vitro we examined the effects of plasma on cell viability…